Image of brain scan to show People with neurological conditions lose out due to COVID-19 delays

People with neurological conditions lose out due to COVID-19 delays

In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Image of a head with a cloud brain to show Post COVID-19 mental health crisis awaits

Without support for services post COVID-19 mental health crisis awaits

The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
healthcare professionals in PPE to show Major study into COVID-19 long-term health effects

Major study into COVID-19 long-term health effects

The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Image of hands signing a contract to show EC approves Janssen's preventative Ebola vaccine

EC approves Janssen’s preventative Ebola vaccine

Johnson & Johnson has announced that the European Commission (EC) has granted Marketing Authorisation for Janssen’s preventive Ebola vaccine. This marks the first major...
Image of a healthcare professional in PPE with medical equipment and rip to show No clear benefit of HIV antivirals for COVID-19 patients

No clear benefit of HIV antivirals for COVID-19 patients, says study

There is no clear benefit of HIV antivirals for COVID-19 patients, says new study by the Drug Safety Research Unit (DSRU) in Southampton. It...
Image of medicines to show Impact of COVID-19 on cancer research funding

Impact of COVID-19 on cancer research funding

Cancer Research UK has announced that the impact of COVID-19 on its income means it could be forced to cut £150m per year from...
Image of a person in full PPE holding a shield with a health cross on it up to the coronavirus to show New consortium to monitor safety and effectiveness of COVID-19 vaccines

New consortium to monitor safety and effectiveness of COVID-19 vaccines

A new consortium to monitor the safety and effectiveness of COVID-19 vaccines has been formed by the Drug Safety Research Unit (DSRU) in Southampton...
Image of coronavirus and a syringe to show Support for developers of COVID-19 medicinal products

Support for developers of COVID-19 medicinal products

The National Institute for Health and Care Excellence (NICE) and the National Institute for Health Research (NIHR) have launched a guide on clinical evidence...
Image of a doctor smiling to show New data show the impact of COVID-19 on private healthcare

Impact of COVID-19 on private healthcare

New data shows the impact of COVID-19 on private healthcare in the UK. The pandemic has led to an estimated 84% drop in privately...
Image of a person sitt9ing in front of numerous tech related icons. to show VR learning platform launched in response to COVID-19

VR learning platform launched in response to COVID-19

Onyx Health are to launch a new VR Learning Platform in response to COVID-19. The Interactive Learning Environment (ILE) is an online communication tool...

Latest articles

New COVID-19 screening technology could test large groups with rapid response

New COVID-19 screening technology could test large groups with rapid response

The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
Scaling up a Covid-19 vaccine

Distribution and scaling up a Covid-19 vaccine

The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Scaling up a Covid-19 vaccine

Distribution and scaling up a Covid-19 vaccine

The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
New COVID-19 screening technology could test large groups with rapid response

New COVID-19 screening technology could test large groups with rapid response

The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription